Catalyst Wire Dossier Catalyst Wire Dossier

SECUADO

ASENAPINE · Noven Therapeutics, LLC
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SECUADO, covering 2019-10-11 to 2025-01-22. Get the full timeline:

Most recent: FDA Approved: SECUADO — Supplemental Application (Noven Therapeutics, LLC)

See pricing